Invest in MeMed private stocks

memed We described the overall feasibility of MeMed BV testing in ED patients presenting to the ED with febrile illness concerning for respiratory tract infection. We. MeMed BV is the first FDA-cleared host

memed4, MeMed BV® delivers a breakthrough in rapid diagnostics Our 15-minute test differentiates between bacterial and viral infections, empowering patients, optimizing provider workflows,.